nach oben

The Journal of Obstetrics and Gynecology of India

Erschienen in:

11.04.2019 | Original Article

The Relationship of Pregnancy-Associated Plasma Protein A and Human Chorionic Gonadotropin with Adverse Pregnancy Outcomes: A Prospective Study

verfasst von: Hamideh Pakniat, MD, Atieh Bahman, MD, Iman Ansari, MD

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This prospective study investigated the relationship between pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG) and adverse pregnancy outcomes in the Iranian population.

Materials

Overall, 994 singleton pregnant mothers of 18–35-year old were referred for first-trimester screening tests, including PAPP-A and β-hCG, at the age of 6 days and 11–13 weeks, and were followed until the end of their pregnancy. The adverse pregnancy outcomes, PAPP-A, and β-hCG serum levels were recorded and analyzed. The sensitivity and specificity of the test were measured by calculating the area under the curve of receiver operating characteristic curve (ROC).

Results

The mean serum level of PAPP-A and β-hCG was 1.10 ± 0.69 and 1.09 ± 0.8 MoM, respectively. Pregnancy-associated plasma protein A, regardless of its percentile, showed a significant relationship with the incidence of preeclampsia, preterm birth, and fetal low birth weight (p < 0.001 for each). However, the relationship between PAPP-A and abortion was not significant (p > 0.05). According to ROC, the results indicated that PAPP-A had a significant relationship with the incidence of preeclampsia, preterm birth, and fetal low birth weight (p < 0.001). However, β-hCG levels showed no significant relationship with adverse pregnancy outcomes.

Conclusions

The result of this study revealed that lower level of PAPP-A and β-hCG could be a predictive factor in preterm labor. Also, this study indicated that PAPP-A measurements could be a screening test for adverse pregnancy outcomes, such as preeclampsia, low birth weight and preterm labor.

Sweeting A, Park F, Hyett J. The first trimester: prediction and prevention of the great obstetrical syndromes. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):183–93. https://doi.org/10.1016/j.bpobgyn.2014.09.006.CrossRefPubMed

Nicolaides KH, Syngelaki A, Poon LC, et al. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn Ther. 2014;35(3):185–92. https://doi.org/10.1159/000356066.CrossRefPubMed

Cignini P, Savasta LM, Gulino FA, et al. Predictive value of pregnancy-associated plasma protein-A (PAPP-A) and free beta-hCG on fetal growth restriction: results of a prospective study. Arch Gynecol Obstet. 2016;293(6):1227–33. https://doi.org/10.1007/s00404-015-3947-z.CrossRefPubMed

Morris RK, Bilagi A, Devani P, et al. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn. 2017;37(3):253–65. https://doi.org/10.1002/pd.5001.CrossRefPubMed

Cohen JL, Smilen KE, Bianco AT, et al. Predictive value of combined serum biomarkers for adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;181:89–94. https://doi.org/10.1016/j.ejogrb.2014.07.018.CrossRefPubMed

Huynh L, Kingdom J, Akhtar S. Low pregnancy-associated plasma protein A level in the first trimester. Can Fam Physician. 2014;60(10):899–903.PubMedPubMedCentral

Luewan S, Teja-Intr M, Sirichotiyakul S, et al. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia. Singap Med J. 2018;59(1):55–9. https://doi.org/10.11622/smedj.2017034.CrossRef

Hansen YB, Myrhøj V, Jørgensen FS, et al. First trimester PAPP-A2, PAPP-A and hCGβ in small-for-gestational-age pregnancies. Clin Chem Lab Med. 2016;54(1):117–23.CrossRef

Jelliffe-Pawlowski LL, Baer RJ, Blumenfeld YJ, et al. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth. BJOG. 2015;122(11):1484–93. https://doi.org/10.1111/1471-0528.13495.CrossRefPubMedPubMedCentral

10.

Saraswathy S, Sahai K, Yadav TP, et al. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein. Pregnancy Hypertens. 2016;6(4):306–12. https://doi.org/10.1016/j.preghy.2016.06.003.CrossRefPubMed

11.

Sung KU, Roh JA, Eoh KJ, et al. Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstet Gynecol Sci. 2017;60(2):154–62. https://doi.org/10.5468/ogs.2017.60.2.154.CrossRefPubMedPubMedCentral

12.

Kharaghani R, Cheraghi Z, Esfahani BO, et al. Prevalence of preeclampsia and eclampsia in Iran. Arch Iran Med. 2016;19(1):64–71. https://doi.org/0161901/AIM.0012.

13.

Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:f6564.CrossRef

14.

Thornton C, Dahlen H, Korda A, et al. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000–2008. Am J Obstet Gynecol. 2013;208:476.e1–5.CrossRef

15.

Perveen S. Frequency and impact of hypertensive disorders of pregnancy. J Ayub Med Coll. 2014;26:518–21.

16.

Pitakkarnkul S, Phaloprakarn C, Wiriyasirivaj B, et al. Seasonal variation in the prevalence of preeclampsia. J Med Assoc Thai. 2011;94:1293–8.PubMed

17.

Cripe S, O’Brien W, Gelaye B, et al. Perinatal outcomes of southeast asians with pregnancies complicated by gestational diabetes mellitus or preeclampsia. J Immigr Minor Health. 2012;14:747–53.CrossRef

18.

Moslemi Zadeh N, Naghshvar F, Peyvandi S, et al. PP13 and PAPP-A in the first and second trimesters: predictive factors for preeclampsia? ISRN Obstet Gynecol. 2012;2012:263871. https://doi.org/10.5402/2012/263871.CrossRefPubMedPubMedCentral

19.

Crosley EJ, Durland U, Seethram K, et al. First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia. Reprod Sci. 2014;21(6):754–60. https://doi.org/10.1177/1933719113512532.CrossRefPubMedPubMedCentral

20.

Patil M, Panchanadikar TM, Wagh G. Variation of PAPP-A level in the first trimester of pregnancy and its clinical outcome. J Obstet Gynaecol India. 2014;64(2):116–9. https://doi.org/10.1007/s13224-013-0481-4.CrossRefPubMed

21.

Jelliffe-Pawlowski LL, Baer RJ, Currier RJ, et al. Early-onset severe preeclampsia by first trimester pregnancy-associated plasma protein A and total human chorionic gonadotropin. Am J Perinatol. 2015;32(7):703–12. https://doi.org/10.1055/s-0034-1396697.CrossRefPubMed

22.

Yliniemi A, Makikallio K, Korpimaki T, et al. Combination of PAPP-A, fhCGβ, AFP, PlGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia. Clin Med Insights Reprod Health. 2015;9:13–20. https://doi.org/10.4137/CMRH.S21865.CrossRefPubMedPubMedCentral

23.

Ozdamar O, Gun I, Keskin U, et al. The role of maternal serumbeta-hCG and PAPP-A levels at gestational weeks 10 to 14 in the prediction of pre-eclampsia. Pak J Med Sci. 2014;30(3):568–73. https://doi.org/10.12669/pjms.303.4554.CrossRefPubMedPubMedCentral

24.

Yücel B, Gedikbasi A, Dündar O, et al. The utility of first trimester uterine artery Doppler, placental volume and PAPP-A levels alone and in combination to predict preeclampsia. Pregnancy Hypertens. 2016;6(4):269–73. https://doi.org/10.1016/j.preghy.2016.04.007.CrossRefPubMed

25.

O’Gorman N, Wright D, Poon LC, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;49(6):751–5. https://doi.org/10.1002/uog.17399.CrossRefPubMed

26.

Karahasanovic A, Sørensen S, Nilas L. First trimester pregnancy-associated plasma protein A and human chorionic gonadotropin-beta in early and late pre-eclampsia. Clin Chem Lab Med. 2014;52(4):521–5. https://doi.org/10.1515/cclm-2013-0338.CrossRefPubMed

27.

Gupta S, Goyal M, Verma D, et al. Adverse pregnancy outcome in patients with low pregnancy-associated plasma protein-A: the Indian experience. J Obstet Gynaecol Res. 2015;41(7):1003–8. https://doi.org/10.1111/jog.12662.CrossRefPubMed

28.

Allen RE, Rogozinska E, Cleverly K, et al. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;182:194–201. https://doi.org/10.1016/j.ejogrb.2014.09.027.CrossRefPubMed

29.

Keikkala E, Koskinen S, Vuorela P, et al. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study. BMC Pregnancy Childbirth. 2016;16(1):378.CrossRef

30.

Kirkegaard I, Uldbjerg N, Petersen OB, et al. PAPP-A, free β-hCG, and early fetal growth identify two pathways leading to preterm delivery. Prenat Diagn. 2010;30(10):956–63. https://doi.org/10.1002/pd.2593.CrossRefPubMed

31.

Gundu S, Kulkarni M, Gupte S, et al. Correlation of first-trimester serum levels of pregnancy-associated plasma protein A with small-for-gestational-age neonates and preterm births. Int J Gynaecol Obstet. 2016;133(2):159–63. https://doi.org/10.1016/j.ijgo.2015.09.022.CrossRefPubMed

32.

Goetzinger KR, Cahill AG, Kemna J, et al. First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics. Prenat Diagn. 2012;32(10):1002–7. https://doi.org/10.1002/pd.3949.CrossRefPubMedPubMedCentral

33.

D’Antonio F, Rijo C, Thilaganathan B, et al. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications. Prenat Diagn. 2013;33(9):839–47. https://doi.org/10.1002/pd.4141.CrossRefPubMed

34.

Dane B, Dane C, Batmaz G, et al. First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies. Gynecol Endocrinol. 2013;29(6):592–5. https://doi.org/10.3109/09513590.2013.788626.CrossRefPubMed

35.

Quattrocchi T, Baviera G, Pochiero T, et al. Maternal serum PAPP-A as an early marker of obstetric complications? Fetal Diagn Ther. 2015;37(1):33–6. https://doi.org/10.1159/000365147.CrossRefPubMed

36.

Kaitu’u-Lino TJ, Bambang K, Onwude J, et al. Plasma MIC-1 and PAPP-a levels are decreased among women presenting to an early pregnancy assessment unit, have fetal viability confirmed but later miscarry. PLoS ONE. 2013;8(9):e72437. https://doi.org/10.1371/journal.pone.0072437.CrossRefPubMedPubMedCentral

37.

Ranta JK, Raatikainen K, Romppanen J, et al. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):48–52. https://doi.org/10.1016/j.ejogrb.2011.03.004.CrossRefPubMed

38.

Krauskopf AL, Knippel AJ, Verde PE, et al. Predicting SGA neonates using first-trimester screening: influence of previous pregnancy’s birthweight and PAPP-A MoM. J Matern Fetal Neonatal Med. 2016;29(18):2962–7. https://doi.org/10.3109/14767058.2015.1109622.CrossRefPubMed

39.

Karagiannis G, Akolekar R, Sarquis R, et al. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther. 2011;29(2):148–54. https://doi.org/10.1159/000321694.CrossRefPubMed

40.

Baer RJ, Lyell DJ, Norton ME, et al. First trimester pregnancy-associated plasma protein-A and birth weight. Eur J Obstet Gynecol Reprod Biol. 2016;198:1–6. https://doi.org/10.1016/j.ejogrb.2015.12.019.CrossRefPubMed

Titel: The Relationship of Pregnancy-Associated Plasma Protein A and Human Chorionic Gonadotropin with Adverse Pregnancy Outcomes: A Prospective Study
verfasst von: Hamideh Pakniat, MD
Atieh Bahman, MD
Iman Ansari, MD
Publikationsdatum: 11.04.2019
Verlag: Springer India
Erschienen in: The Journal of Obstetrics and Gynecology of India / Ausgabe 5/2019
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI: https://doi.org/10.1007/s13224-019-01217-3

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

The Relationship of Pregnancy-Associated Plasma Protein A and Human Chorionic Gonadotropin with Adverse Pregnancy Outcomes: A Prospective Study

Abstract

Purpose

Materials

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Purpose

Materials

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Obstetric Complications of Donor Egg Conception Pregnancies

A Multicenter, Randomized, Open-Label Trial Comparing the Efficacy and Safety of Monoclonal Anti-Rh (D) Immunoglobulin with Polyclonal Anti-Rh (D) Immunoglobulin for the Prevention of Maternal Rh-Isoimmunization

Thyroid-Stimulating Hormone Values in Pregnancy: Cutoff Controversy Continues?

Predictive Value of Single Serum Progesterone Level for Viability in Threatened Miscarriage

Validation of the Risk Score for Maternal Cardiac Complications in Women with Cardiac Disease in Pregnancy: A Retrospective Study

Gross Hematuria in Pregnancy: An Enigma

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie